Humans are protected by two branches of the immune system. Innate immunity provides built-in defense against widespread characteristics of bacteria and viruses, while adaptive immunity memorizes ...

The articles in this focus issue discuss progress towards a more complete understanding of memory in the innate immune system, and efforts to exploit "trained immunity" for the development of new ...

Our immune system is divided into two main branches: innate and adaptive. Innate immune cells act as a first line of defense, quickly responding to invaders, while adaptive immune cells take a longer ...

A new review by Dr. Ruyuan Wang and an international team of researchers explores the complex interactions between the innate and adaptive immune systems, shedding light on regulatory mechanisms in ...

Scientists discover how innate immunity envelops bacteria. The protein GBP1 is a vital component of our body's natural defense against pathogens. This substance fights against bacteria and parasites ...

Our latest Focus Issue looks at what we’ve learnt over the past decade and what’s next for the field of trained immunity.

Immunologists have identified an important intermediate step in innate immune defense. If bacteria enter the body, it often takes just a few minutes for the innate immune system to recognise them as ...

The question of the protection afforded by COVID infection vs. the immunity conferred by the mRNA vaccines is still unsettled. A new study may put our concerns to rest. Spoiler alert: each form of ...

Training Non-Oncologist Healthcare Providers to Manage Oral Endocrine Therapy for Breast Cancer The immune system of living being has evolved via the action of immune defense mechanism by utilizing ...

Clarivate plc has unveiled the 2025 Citation Laureates. Widely considered a predictor of the Nobel Prizes, this recognition has highlighted the discovery of biomolecular condensates in chemistry and ...

Allowing the virus to grow unchecked would create unthinkable loss of life. On June 26, Dr. Anthony Fauci announced it's "unlikely" that a COVID-19 vaccine with 70-75% efficacy taken by two-thirds of ...